IGF2BP1 and neoplasm: The expression levels of RBM15B (p = 0.037), HNRNPC (p = 0.001), METTL14 (p = 0.007), METTL3 (p = 0.005), YTHDC1 (p = 0.049), KIAA1429 (p = 0.010), ALKBH5 (p = 3.50E-06), YTHF2 (p = 0.038), HNRN p A2B1 (p = 0.003), IGF2BP1 (p = 1.22E-11), IGF2BP2 (p = 1.10E-05), and IGF2BP3 (p = 2.34E-27) showed a significant dysregulation in tumor samples between different clusters.